GY, B., S, S., R, X., AC, B., KM, O., P, J., . . . B, S. (2026). Genomic heterogeneity of NAD(P)H dehydrogenase predisposes Cryptosporidium to clofazimine resistance. Nature microbiology, 11(6), 1559. https://doi.org/10.1038/s41564-026-02331-5
Chicago Style (17th ed.) CitationGY, Buenconsejo, et al. "Genomic Heterogeneity of NAD(P)H Dehydrogenase Predisposes Cryptosporidium to Clofazimine Resistance." Nature Microbiology 11, no. 6 (2026): 1559. https://doi.org/10.1038/s41564-026-02331-5.
MLA (9th ed.) CitationGY, Buenconsejo, et al. "Genomic Heterogeneity of NAD(P)H Dehydrogenase Predisposes Cryptosporidium to Clofazimine Resistance." Nature Microbiology, vol. 11, no. 6, 2026, p. 1559, https://doi.org/10.1038/s41564-026-02331-5.
Warning: These citations may not always be 100% accurate.